MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma-Trial in progress

Daniel V.T. Catenacci; John H. Strickler; Yoshiaki Nakamura; Kohei Shitara; Yelena Y. Janjigian; Afsaneh Barzi; Tanios S. Bekaii-Saab; Heinz-Josef Lenz; Hyun Cheol Cheol Chung; Josep Tabernero; Takayuki Yoshino; Salvatore Siena; Joal Garrido Mayor; Maria Corinna Palanca-Wessels; Diqiong Xie; John Marshall

doi:10.1200/JCO.2022.40.4_suppl.TPS371

YUHSpace

BROWSE

Cited 0 times in

MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma-Trial in progress

Authors: Daniel V.T. Catenacci ; John H. Strickler ; Yoshiaki Nakamura ; Kohei Shitara ; Yelena Y. Janjigian ; Afsaneh Barzi ; Tanios S. Bekaii-Saab ; Heinz-Josef Lenz ; Hyun Cheol Cheol Chung ; Josep Tabernero ; Takayuki Yoshino ; Salvatore Siena ; Joal Garrido Mayor ; Maria Corinna Palanca-Wessels ; Diqiong Xie ; John Marshall